 Nirmal Banda
Concepts (336)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Experimental | 29 | 2021 | 130 | 7.490 |
Why?
| | Complement Pathway, Alternative | 13 | 2020 | 114 | 3.610 |
Why?
| | Complement Activation | 17 | 2023 | 340 | 3.210 |
Why?
| | Arthritis, Rheumatoid | 14 | 2023 | 1003 | 3.070 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 8 | 2020 | 24 | 2.890 |
Why?
| | Complement System Proteins | 11 | 2023 | 283 | 2.670 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 7 | 2020 | 20 | 2.570 |
Why?
| | Complement C3 | 14 | 2023 | 188 | 1.590 |
Why?
| | Complement Factor D | 6 | 2020 | 26 | 1.570 |
Why?
| | Mice, Knockout | 23 | 2021 | 2568 | 1.290 |
Why?
| | Complement Factor H | 5 | 2017 | 60 | 1.270 |
Why?
| | Collagen Type II | 8 | 2019 | 48 | 1.160 |
Why?
| | Mice, Inbred C57BL | 23 | 2021 | 4692 | 1.010 |
Why?
| | Synovial Membrane | 5 | 2022 | 75 | 1.000 |
Why?
| | Receptors, Complement 3b | 3 | 2023 | 81 | 0.980 |
Why?
| | Mice | 46 | 2023 | 14863 | 0.970 |
Why?
| | Antigen-Antibody Complex | 4 | 2017 | 84 | 0.940 |
Why?
| | Joints | 5 | 2020 | 84 | 0.910 |
Why?
| | Receptor, Anaphylatoxin C5a | 2 | 2015 | 28 | 0.870 |
Why?
| | Meniscus | 1 | 2023 | 21 | 0.840 |
Why?
| | Receptors, Complement 3d | 4 | 2023 | 130 | 0.760 |
Why?
| | Dextrans | 4 | 2016 | 73 | 0.750 |
Why?
| | Anterior Cruciate Ligament Injuries | 1 | 2023 | 130 | 0.740 |
Why?
| | Receptors, Complement | 3 | 2018 | 111 | 0.740 |
Why?
| | Animals | 50 | 2023 | 31698 | 0.740 |
Why?
| | RNA, Small Interfering | 4 | 2020 | 535 | 0.730 |
Why?
| | Single-Chain Antibodies | 1 | 2020 | 14 | 0.720 |
Why?
| | Synoviocytes | 1 | 2020 | 10 | 0.720 |
Why?
| | Complement C5 | 3 | 2015 | 73 | 0.700 |
Why?
| | Osteoarthritis, Knee | 1 | 2023 | 213 | 0.700 |
Why?
| | Immunoglobulin M | 2 | 2020 | 246 | 0.670 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2023 | 246 | 0.660 |
Why?
| | RNA Interference | 2 | 2020 | 433 | 0.630 |
Why?
| | Complement Inactivator Proteins | 3 | 2009 | 40 | 0.620 |
Why?
| | Lectins | 2 | 2019 | 42 | 0.610 |
Why?
| | Antirheumatic Agents | 1 | 2020 | 255 | 0.600 |
Why?
| | Recombinant Fusion Proteins | 4 | 2023 | 616 | 0.600 |
Why?
| | Collagen | 5 | 2017 | 415 | 0.580 |
Why?
| | Complement Pathway, Classical | 3 | 2014 | 19 | 0.570 |
Why?
| | Antibodies, Monoclonal | 5 | 2011 | 1262 | 0.510 |
Why?
| | Nanoparticles | 4 | 2023 | 313 | 0.490 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 2015 | 53 | 0.490 |
Why?
| | Inflammation | 5 | 2021 | 2478 | 0.480 |
Why?
| | Immunoglobulin G | 6 | 2011 | 770 | 0.470 |
Why?
| | Adenoviridae | 2 | 2014 | 184 | 0.460 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1313 | 0.450 |
Why?
| | Complement C3a | 2 | 2011 | 33 | 0.430 |
Why?
| | Immunization, Passive | 2 | 2018 | 73 | 0.420 |
Why?
| | Complement C6 | 2 | 2011 | 9 | 0.420 |
Why?
| | Contrast Media | 1 | 2014 | 345 | 0.400 |
Why?
| | Adipocytes | 1 | 2013 | 188 | 0.380 |
Why?
| | Autoimmune Diseases | 1 | 2014 | 382 | 0.370 |
Why?
| | Autoantibodies | 6 | 2023 | 1346 | 0.340 |
Why?
| | Collectins | 2 | 2021 | 12 | 0.340 |
Why?
| | Complement C5a | 1 | 2009 | 59 | 0.330 |
Why?
| | HIV-1 | 6 | 2002 | 768 | 0.330 |
Why?
| | Magnetite Nanoparticles | 4 | 2019 | 28 | 0.330 |
Why?
| | Cytokines | 7 | 2021 | 1840 | 0.330 |
Why?
| | Disease Models, Animal | 11 | 2021 | 3531 | 0.330 |
Why?
| | RNA, Messenger | 8 | 2022 | 2552 | 0.320 |
Why?
| | Complement Factor B | 3 | 2021 | 100 | 0.320 |
Why?
| | Fibroblasts | 1 | 2013 | 838 | 0.310 |
Why?
| | Polysaccharides | 1 | 2008 | 78 | 0.300 |
Why?
| | Humans | 39 | 2023 | 114654 | 0.300 |
Why?
| | Complement Inactivating Agents | 2 | 2020 | 41 | 0.300 |
Why?
| | Neutrophils | 4 | 2020 | 1176 | 0.280 |
Why?
| | Mice, Inbred DBA | 4 | 2020 | 173 | 0.280 |
Why?
| | Blotting, Western | 4 | 2013 | 1147 | 0.260 |
Why?
| | Leukocytes | 2 | 2019 | 276 | 0.260 |
Why?
| | Gene Expression | 2 | 2022 | 1421 | 0.260 |
Why?
| | CD4 Antigens | 2 | 1999 | 123 | 0.250 |
Why?
| | Complement C1q | 4 | 2009 | 36 | 0.250 |
Why?
| | Sialoglycoproteins | 2 | 2005 | 159 | 0.250 |
Why?
| | Cartilage, Articular | 2 | 2006 | 289 | 0.250 |
Why?
| | Male | 21 | 2021 | 55579 | 0.240 |
Why?
| | Immunohistochemistry | 4 | 2013 | 1629 | 0.240 |
Why?
| | Glycoproteins | 2 | 2003 | 304 | 0.230 |
Why?
| | Hydrolases | 2 | 2017 | 51 | 0.220 |
Why?
| | Tissue Distribution | 2 | 2022 | 286 | 0.220 |
Why?
| | Keratinocytes | 1 | 2005 | 216 | 0.220 |
Why?
| | Disease Susceptibility | 2 | 2018 | 316 | 0.220 |
Why?
| | Cells, Cultured | 4 | 2020 | 3885 | 0.210 |
Why?
| | Antigens, CD34 | 3 | 2002 | 89 | 0.210 |
Why?
| | Lipopolysaccharides | 3 | 2020 | 821 | 0.210 |
Why?
| | Mannose-Binding Lectin | 2 | 2016 | 20 | 0.210 |
Why?
| | Protein Kinases | 1 | 2005 | 307 | 0.210 |
Why?
| | HIV Infections | 6 | 2002 | 2469 | 0.210 |
Why?
| | Lupus Erythematosus, Systemic | 3 | 2014 | 219 | 0.200 |
Why?
| | Interleukin-18 | 2 | 2003 | 219 | 0.200 |
Why?
| | Macrophages | 6 | 2015 | 1261 | 0.200 |
Why?
| | Severity of Illness Index | 5 | 2022 | 2537 | 0.200 |
Why?
| | Complement C3b Inactivator Proteins | 1 | 2021 | 9 | 0.200 |
Why?
| | Thrombin | 2 | 2021 | 139 | 0.200 |
Why?
| | Proto-Oncogene Proteins | 1 | 2005 | 608 | 0.190 |
Why?
| | Trypsin | 1 | 2021 | 66 | 0.180 |
Why?
| | Protein Binding | 5 | 2019 | 1889 | 0.180 |
Why?
| | Cartilage | 4 | 2019 | 182 | 0.180 |
Why?
| | Apoptosis | 4 | 2020 | 2362 | 0.180 |
Why?
| | Thymocytes | 1 | 2020 | 28 | 0.180 |
Why?
| | Cytotoxicity, Immunologic | 2 | 1998 | 195 | 0.180 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 89 | 0.170 |
Why?
| | Transfection | 2 | 2020 | 866 | 0.170 |
Why?
| | CD55 Antigens | 1 | 2019 | 27 | 0.160 |
Why?
| | Complement C3 Convertase, Alternative Pathway | 1 | 2018 | 2 | 0.160 |
Why?
| | Lymphocyte Activation | 3 | 2003 | 1037 | 0.160 |
Why?
| | Pancytopenia | 1 | 1999 | 7 | 0.160 |
Why?
| | Macular Degeneration | 1 | 2020 | 152 | 0.160 |
Why?
| | Cattle | 3 | 2009 | 921 | 0.160 |
Why?
| | Antibodies | 2 | 2019 | 371 | 0.160 |
Why?
| | Autoimmunity | 3 | 2016 | 813 | 0.160 |
Why?
| | Lymphocytes | 1 | 2020 | 330 | 0.150 |
Why?
| | Genetic Therapy | 3 | 2008 | 257 | 0.150 |
Why?
| | Diphtheria Toxin | 1 | 1998 | 51 | 0.150 |
Why?
| | Complement C4 | 2 | 2009 | 25 | 0.150 |
Why?
| | Atherosclerosis | 1 | 2021 | 341 | 0.150 |
Why?
| | Archaeal Viruses | 1 | 2017 | 6 | 0.150 |
Why?
| | Bone Marrow Cells | 1 | 1999 | 267 | 0.150 |
Why?
| | Monocytes | 1 | 2020 | 502 | 0.140 |
Why?
| | Ferric Compounds | 2 | 2014 | 41 | 0.140 |
Why?
| | Genetic Variation | 2 | 2021 | 870 | 0.140 |
Why?
| | Surface Properties | 2 | 2015 | 387 | 0.140 |
Why?
| | Fetal Blood | 1 | 1998 | 270 | 0.140 |
Why?
| | Bleomycin | 1 | 2018 | 228 | 0.130 |
Why?
| | Biomarkers | 2 | 2018 | 3408 | 0.130 |
Why?
| | Coated Materials, Biocompatible | 1 | 2016 | 54 | 0.130 |
Why?
| | T-Lymphocyte Subsets | 2 | 2003 | 383 | 0.130 |
Why?
| | Mucin-5B | 1 | 2018 | 183 | 0.130 |
Why?
| | Proteolysis | 1 | 2016 | 142 | 0.130 |
Why?
| | Benzimidazoles | 1 | 2017 | 138 | 0.130 |
Why?
| | T-Lymphocytes | 4 | 2021 | 1737 | 0.130 |
Why?
| | Protein Processing, Post-Translational | 1 | 2018 | 399 | 0.130 |
Why?
| | Opsonin Proteins | 1 | 2015 | 25 | 0.130 |
Why?
| | Signal Transduction | 3 | 2020 | 4512 | 0.130 |
Why?
| | Spleen | 4 | 2008 | 487 | 0.120 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2319 | 0.120 |
Why?
| | Inflammation Mediators | 1 | 2018 | 477 | 0.120 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 923 | 0.120 |
Why?
| | Synovial Fluid | 2 | 2011 | 56 | 0.120 |
Why?
| | Polymerase Chain Reaction | 3 | 2020 | 993 | 0.120 |
Why?
| | Mice, Inbred NZB | 1 | 2014 | 15 | 0.120 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2014 | 37 | 0.120 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 797 | 0.120 |
Why?
| | Peptide Fragments | 1 | 1998 | 666 | 0.120 |
Why?
| | Ross River virus | 1 | 2014 | 22 | 0.120 |
Why?
| | Immunity, Innate | 2 | 2017 | 720 | 0.110 |
Why?
| | Transduction, Genetic | 1 | 2014 | 113 | 0.110 |
Why?
| | Alphavirus Infections | 1 | 2014 | 41 | 0.110 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 532 | 0.110 |
Why?
| | Species Specificity | 1 | 2014 | 542 | 0.110 |
Why?
| | Laser Capture Microdissection | 1 | 2013 | 23 | 0.110 |
Why?
| | Genotype | 1 | 2018 | 1760 | 0.110 |
Why?
| | Biological Transport | 3 | 2020 | 373 | 0.110 |
Why?
| | Lymphocyte Subsets | 2 | 2003 | 79 | 0.110 |
Why?
| | Alternative Splicing | 1 | 2014 | 187 | 0.100 |
Why?
| | Female | 11 | 2021 | 59488 | 0.100 |
Why?
| | Mice, Inbred NOD | 1 | 2014 | 555 | 0.100 |
Why?
| | HIV Envelope Protein gp120 | 1 | 1992 | 56 | 0.100 |
Why?
| | Liver | 1 | 2020 | 1637 | 0.100 |
Why?
| | Knee Joint | 1 | 2015 | 323 | 0.100 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1143 | 0.100 |
Why?
| | Carotid Artery Thrombosis | 1 | 2011 | 7 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 501 | 0.100 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2018 | 505 | 0.100 |
Why?
| | Complement Membrane Attack Complex | 1 | 2011 | 33 | 0.100 |
Why?
| | Interleukin-1 | 3 | 2005 | 966 | 0.090 |
Why?
| | HIV | 1 | 1992 | 208 | 0.090 |
Why?
| | Amidines | 1 | 2011 | 16 | 0.090 |
Why?
| | Ornithine | 1 | 2011 | 18 | 0.090 |
Why?
| | RNA, Catalytic | 2 | 2002 | 182 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 1727 | 0.090 |
Why?
| | Lymph Nodes | 3 | 2008 | 419 | 0.090 |
Why?
| | Blood Coagulation | 1 | 2011 | 218 | 0.090 |
Why?
| | Binding Sites | 2 | 2021 | 1168 | 0.090 |
Why?
| | Acquired Immunodeficiency Syndrome | 3 | 1999 | 217 | 0.080 |
Why?
| | Receptors, CCR5 | 2 | 2000 | 54 | 0.080 |
Why?
| | Osteoarthritis | 1 | 2011 | 171 | 0.080 |
Why?
| | Serum | 1 | 2009 | 57 | 0.080 |
Why?
| | Foot | 1 | 2009 | 103 | 0.080 |
Why?
| | Drug Combinations | 1 | 2009 | 287 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 1994 | 959 | 0.080 |
Why?
| | Zymosan | 1 | 2007 | 64 | 0.070 |
Why?
| | Peptides | 1 | 2013 | 848 | 0.070 |
Why?
| | Cations, Divalent | 1 | 2007 | 51 | 0.070 |
Why?
| | Immune Sera | 1 | 2007 | 79 | 0.070 |
Why?
| | Enzyme Inhibitors | 1 | 2011 | 750 | 0.070 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 2005 | 254 | 0.070 |
Why?
| | B-Lymphocytes | 1 | 2012 | 766 | 0.070 |
Why?
| | Immunosuppressive Agents | 1 | 2011 | 646 | 0.070 |
Why?
| | Adult | 5 | 2021 | 30542 | 0.060 |
Why?
| | Calcium | 2 | 2012 | 1108 | 0.060 |
Why?
| | Gene Transfer Techniques | 3 | 2008 | 147 | 0.060 |
Why?
| | DNA | 1 | 2012 | 1352 | 0.060 |
Why?
| | Phosphorylation | 2 | 2012 | 1569 | 0.060 |
Why?
| | Lung | 1 | 2018 | 3559 | 0.060 |
Why?
| | COP9 Signalosome Complex | 1 | 2005 | 6 | 0.060 |
Why?
| | Two-Hybrid System Techniques | 1 | 2005 | 52 | 0.060 |
Why?
| | Extracellular Fluid | 1 | 2004 | 30 | 0.060 |
Why?
| | Mice, SCID | 3 | 2002 | 314 | 0.060 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2003 | 351 | 0.060 |
Why?
| | Rats | 2 | 2023 | 4958 | 0.060 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 260 | 0.060 |
Why?
| | Interleukin-8 | 1 | 2005 | 237 | 0.060 |
Why?
| | Citrulline | 2 | 2017 | 40 | 0.060 |
Why?
| | Injections, Intradermal | 1 | 2003 | 12 | 0.060 |
Why?
| | HeLa Cells | 1 | 2005 | 562 | 0.050 |
Why?
| | Cross-Linking Reagents | 2 | 2015 | 181 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1016 | 0.050 |
Why?
| | Hindlimb | 1 | 2003 | 130 | 0.050 |
Why?
| | Lymphocyte Count | 1 | 2003 | 133 | 0.050 |
Why?
| | Superoxide Dismutase | 1 | 2004 | 305 | 0.050 |
Why?
| | Receptors, CXCR4 | 2 | 2002 | 78 | 0.050 |
Why?
| | Middle Aged | 5 | 2021 | 26732 | 0.050 |
Why?
| | Cell Count | 1 | 2003 | 303 | 0.050 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1230 | 0.050 |
Why?
| | Blood Sedimentation | 1 | 2021 | 32 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2003 | 1947 | 0.050 |
Why?
| | Chromosome Deletion | 1 | 2021 | 95 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2004 | 1139 | 0.050 |
Why?
| | Rats, Long-Evans | 1 | 2021 | 98 | 0.050 |
Why?
| | Sequence Deletion | 1 | 2021 | 167 | 0.050 |
Why?
| | Homozygote | 1 | 2021 | 187 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2005 | 676 | 0.050 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1518 | 0.050 |
Why?
| | Antigen-Presenting Cells | 1 | 2021 | 150 | 0.050 |
Why?
| | Necrosis | 1 | 2021 | 211 | 0.050 |
Why?
| | Hematopoietic Stem Cells | 2 | 2002 | 343 | 0.050 |
Why?
| | Bone and Bones | 2 | 2017 | 278 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2005 | 591 | 0.040 |
Why?
| | Organ Specificity | 2 | 2016 | 268 | 0.040 |
Why?
| | Dogs | 1 | 2021 | 334 | 0.040 |
Why?
| | Retinal Pigment Epithelium | 1 | 2020 | 58 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2021 | 353 | 0.040 |
Why?
| | Choroidal Neovascularization | 1 | 2020 | 44 | 0.040 |
Why?
| | Adaptive Immunity | 1 | 2021 | 155 | 0.040 |
Why?
| | Tomography, Optical Coherence | 1 | 2020 | 130 | 0.040 |
Why?
| | Complement C3-C5 Convertases | 1 | 2019 | 19 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2021 | 362 | 0.040 |
Why?
| | Ferrosoferric Oxide | 1 | 2019 | 25 | 0.040 |
Why?
| | Cardiology | 1 | 2021 | 259 | 0.040 |
Why?
| | HIV Seronegativity | 1 | 1999 | 24 | 0.040 |
Why?
| | Nanomedicine | 1 | 2019 | 28 | 0.040 |
Why?
| | Proteomics | 2 | 2017 | 836 | 0.040 |
Why?
| | Fetal Tissue Transplantation | 1 | 1998 | 35 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2020 | 301 | 0.040 |
Why?
| | Clone Cells | 1 | 1999 | 247 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3252 | 0.040 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2019 | 90 | 0.040 |
Why?
| | Tobacco Products | 1 | 2019 | 98 | 0.040 |
Why?
| | A549 Cells | 1 | 2018 | 51 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 1999 | 109 | 0.040 |
Why?
| | Lipids | 1 | 2021 | 580 | 0.040 |
Why?
| | Extremophiles | 1 | 2017 | 2 | 0.040 |
Why?
| | Sulfolobus | 1 | 2017 | 11 | 0.040 |
Why?
| | HLA-DR Antigens | 1 | 1999 | 219 | 0.040 |
Why?
| | Doxorubicin | 1 | 2019 | 285 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 296 | 0.040 |
Why?
| | Immunity, Mucosal | 1 | 2018 | 84 | 0.040 |
Why?
| | Phylogeny | 1 | 2021 | 789 | 0.040 |
Why?
| | Rabbits | 1 | 2018 | 733 | 0.040 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2017 | 135 | 0.040 |
Why?
| | Epitopes | 1 | 2019 | 435 | 0.040 |
Why?
| | Oxygen | 1 | 2021 | 854 | 0.040 |
Why?
| | Amino Acid Sequence | 1 | 2021 | 1982 | 0.030 |
Why?
| | Sheep | 1 | 2018 | 764 | 0.030 |
Why?
| | Protein Conformation | 1 | 2019 | 805 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 344 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2018 | 485 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2019 | 366 | 0.030 |
Why?
| | Sodium Hydroxide | 1 | 2014 | 8 | 0.030 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2015 | 73 | 0.030 |
Why?
| | Endocytosis | 1 | 2015 | 148 | 0.030 |
Why?
| | Half-Life | 1 | 2014 | 141 | 0.030 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 1995 | 68 | 0.030 |
Why?
| | Polyethylene Glycols | 1 | 2019 | 561 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2016 | 275 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1131 | 0.030 |
Why?
| | Particle Size | 1 | 2014 | 317 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2016 | 347 | 0.030 |
Why?
| | Blood Platelets | 1 | 2015 | 351 | 0.030 |
Why?
| | Gamma Rays | 1 | 1992 | 48 | 0.030 |
Why?
| | Disease Progression | 1 | 2019 | 2380 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1314 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2019 | 3003 | 0.020 |
Why?
| | Surface Plasmon Resonance | 1 | 2012 | 81 | 0.020 |
Why?
| | Smoking | 1 | 2019 | 1381 | 0.020 |
Why?
| | Temperature | 1 | 2014 | 565 | 0.020 |
Why?
| | Mannose-Binding Lectins | 1 | 2011 | 13 | 0.020 |
Why?
| | CD59 Antigens | 1 | 2011 | 21 | 0.020 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2011 | 23 | 0.020 |
Why?
| | Clonal Anergy | 1 | 2012 | 53 | 0.020 |
Why?
| | Body Mass Index | 1 | 2019 | 1958 | 0.020 |
Why?
| | Epidermolysis Bullosa Acquisita | 1 | 2011 | 6 | 0.020 |
Why?
| | Pemphigoid, Bullous | 1 | 2011 | 7 | 0.020 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2012 | 107 | 0.020 |
Why?
| | Protein-Arginine Deiminases | 1 | 2011 | 16 | 0.020 |
Why?
| | Chlorides | 1 | 2011 | 127 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 157 | 0.020 |
Why?
| | Interferon-gamma | 2 | 2004 | 719 | 0.020 |
Why?
| | DNA Damage | 1 | 1992 | 351 | 0.020 |
Why?
| | Immunoglobulin A | 1 | 2011 | 166 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 796 | 0.020 |
Why?
| | Chondrocytes | 1 | 2011 | 199 | 0.020 |
Why?
| | Base Sequence | 2 | 2003 | 2114 | 0.020 |
Why?
| | Peptides, Cyclic | 1 | 2011 | 253 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2008 | 396 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2008 | 289 | 0.020 |
Why?
| | Adiponectin | 1 | 2008 | 213 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2012 | 2762 | 0.010 |
Why?
| | Phenotype | 1 | 2012 | 2796 | 0.010 |
Why?
| | Chemokine CXCL2 | 1 | 2003 | 41 | 0.010 |
Why?
| | Aged | 1 | 2021 | 19068 | 0.010 |
Why?
| | Antibody Formation | 1 | 2004 | 266 | 0.010 |
Why?
| | rev Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 5 | 0.010 |
Why?
| | Gene Products, rev | 1 | 2002 | 5 | 0.010 |
Why?
| | Gene Products, tat | 1 | 2002 | 19 | 0.010 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 20 | 0.010 |
Why?
| | Mitogens | 1 | 2002 | 58 | 0.010 |
Why?
| | DNA Primers | 1 | 2003 | 510 | 0.010 |
Why?
| | Chemokines | 1 | 2003 | 216 | 0.010 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2002 | 80 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2003 | 338 | 0.010 |
Why?
| | Thymus Gland | 1 | 2002 | 296 | 0.010 |
Why?
| | Cell Lineage | 1 | 2002 | 309 | 0.010 |
Why?
| | CCR5 Receptor Antagonists | 1 | 2000 | 6 | 0.010 |
Why?
| | Colony-Forming Units Assay | 1 | 2000 | 88 | 0.010 |
Why?
| | Immunophenotyping | 1 | 2000 | 274 | 0.010 |
Why?
| | Down-Regulation | 1 | 2000 | 594 | 0.010 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2002 | 520 | 0.010 |
Why?
| | Cell Line | 1 | 2002 | 2635 | 0.010 |
Why?
| | Liver Transplantation | 1 | 2002 | 707 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2002 | 1700 | 0.010 |
Why?
| | Macaca | 1 | 1995 | 50 | 0.010 |
Why?
| | Simian Immunodeficiency Virus | 1 | 1995 | 70 | 0.010 |
Why?
| | RNA, Viral | 1 | 1995 | 565 | 0.010 |
Why?
| | Child, Preschool | 1 | 1995 | 9111 | 0.000 |
Why?
| | Child | 1 | 1995 | 18407 | 0.000 |
Why?
|
|
Banda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|